Leidinger P - Search Results

1

Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.

Leidinger P, Hart M, Backes C, Rheinheimer S, Keck B, Wullich B, Keller A, Meese E. Leidinger P, et al. Tumour Biol. 2016 Aug;37(8):10177-85. doi: 10.1007/s13277-016-4883-7. Epub 2016 Jan 29. Tumour Biol. 2016. PMID: 26831660 Clinical Trial.

2

MicroRNA expression changes after lung cancer resection: a follow-up study.

Leidinger P, Keller A, Backes C, Huwer H, Meese E. Leidinger P, et al. RNA Biol. 2012 Jun;9(6):900-10. doi: 10.4161/rna.20107. Epub 2012 Jun 1. RNA Biol. 2012. PMID: 22664918 Free article.

3

Treatment-independent miRNA signature in blood of Wilms tumor patients.

Schmitt J, Backes C, Nourkami-Tutdibi N, Leidinger P, Deutscher S, Beier M, Gessler M, Graf N, Lenhof HP, Keller A, Meese E. Schmitt J, et al. Among authors: leidinger p. BMC Genomics. 2012 Aug 7;13:379. doi: 10.1186/1471-2164-13-379. BMC Genomics. 2012. PMID: 22871070 Free PMC article.

4

Blood born miRNAs signatures that can serve as disease specific biomarkers are not significantly affected by overall fitness and exercise.

Backes C, Leidinger P, Keller A, Hart M, Meyer T, Meese E, Hecksteden A. Backes C, et al. Among authors: leidinger p. PLoS One. 2014 Jul 10;9(7):e102183. doi: 10.1371/journal.pone.0102183. eCollection 2014. PLoS One. 2014. PMID: 25010680 Free PMC article.

5

The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases.

Leidinger P, Backes C, Blatt M, Keller A, Huwer H, Lepper P, Bals R, Meese E. Leidinger P, et al. Mol Cancer. 2014 Aug 30;13:202. doi: 10.1186/1476-4598-13-202. Mol Cancer. 2014. PMID: 25175044 Free PMC article.

6

What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls.

Leidinger P, Backes C, Dahmke IN, Galata V, Huwer H, Stehle I, Bals R, Keller A, Meese E. Leidinger P, et al. Oncotarget. 2014 Oct 15;5(19):9484-97. doi: 10.18632/oncotarget.2419. Oncotarget. 2014. PMID: 25344866 Free PMC article.

7

Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.

Leidinger P, Keller A, Milchram L, Harz C, Hart M, Werth A, Lenhof HP, Weinhäusel A, Keck B, Wullich B, Ludwig N, Meese E. Leidinger P, et al. PLoS One. 2015 Jun 3;10(6):e0128235. doi: 10.1371/journal.pone.0128235. eCollection 2015. PLoS One. 2015. PMID: 26039628 Free PMC article.

8

Longitudinal study on circulating miRNAs in patients after lung cancer resection.

Leidinger P, Galata V, Backes C, Stähler C, Rheinheimer S, Huwer H, Meese E, Keller A. Leidinger P, et al. Oncotarget. 2015 Jun 30;6(18):16674-85. doi: 10.18632/oncotarget.4322. Oncotarget. 2015. PMID: 26078336 Free PMC article.

9

Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance.

Leidinger P, Backes C, Rheinheimer S, Keller A, Meese E. Leidinger P, et al. PLoS One. 2015 Nov 23;10(11):e0143321. doi: 10.1371/journal.pone.0143321. eCollection 2015. PLoS One. 2015. PMID: 26599228 Free PMC article.

10

High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.

Leidinger P, Brefort T, Backes C, Krapp M, Galata V, Beier M, Kohlhaas J, Huwer H, Meese E, Keller A. Leidinger P, et al. Oncotarget. 2016 Jan 26;7(4):4611-23. doi: 10.18632/oncotarget.6566. Oncotarget. 2016. PMID: 26672767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters